睡眠行为与中老年人多病共存进展:中国前瞻性队列研究
该研究基于中国健康与养老追踪调查(CHARLS)2011-2018年8 937名45岁及以上人群的前瞻性队列,分析睡眠时长、睡眠质量及午睡与多病共存进展的关联。结果显示,短睡眠时长和睡眠质量差独立且联合地与多病共存进展风险升高相关,尤其在65岁以下人群和女性中;夜间及总睡眠时长与多病共存进展呈U型剂量反应关系。持续短睡眠和睡眠行为不稳定变化增加多病共存进展风险。
要点
- 短睡眠时长和睡眠质量差独立且联合地与多病共存进展风险升高相关,尤其在65岁以下人群和女性中。
- 夜间及总睡眠时长与多病共存进展呈U型剂量反应关系。
- 持续短睡眠和睡眠行为不稳定变化增加多病共存进展风险。
核心结论
- 短睡眠时长和睡眠质量差独立且联合地与中老年人群多病共存进展风险升高相关。
研究设计与样本
- 数据来自中国健康与养老追踪调查(CHARLS)2011-2018年队列,纳入8 937名45岁及以上个体。
- 睡眠时长、睡眠质量和午睡时长于2011年和2013年收集。
- 多病共存进展定义为:无多病共存者首次报告2种及以上慢性病,或已有多病共存者新报告1种及以上慢性病。
- 采用Cox回归模型计算睡眠行为与多病共存进展关联的风险比(HR)及95%置信区间(CI)。
主要发现
- 短睡眠时长和睡眠质量差与多病共存进展独立且联合相关,尤其在65岁以下人群和女性中。
- 夜间及总睡眠时长与多病共存进展呈U型剂量反应关系。
- 持续短睡眠和睡眠行为不稳定变化增加多病共存进展风险。
- 与每晚睡7-8小时且每周不安稳天数<1天者相比,每晚睡≤5小时且每周不安稳天数5-7天者多病共存进展风险升高1.53倍(95% CI:1.37-1.71)。
关键数值与推荐
- 多病共存进展定义:无多病共存者首次报告≥2种慢性病,或已有多病共存者新报告≥1种慢性病。
- 每晚睡≤5小时且每周不安稳天数5-7天者,多病共存进展风险为每晚睡7-8小时且每周不安稳天数<1天者的1.53倍(95% CI:1.37-1.71)。
临床怎么用
- 在多病共存预防和控制中应重视最佳睡眠时长和睡眠质量。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sleep behavior (eg, sleep duration, sleep quality, and nap) is closely related to many chronic conditions. However, less is known about its association with multiple chronic conditions (multimorbidity), particularly evidence from cohort studies. METHODS: Data were collected from a cohort of 8 937 individuals aged 45 and older from the China Health and Retirement Longitudinal Study (2011-2018). Sleep duration, sleep quality, and nap duration were collected in 2011 and 2013. Progression of multimorbidity was defined as the first report of 2 or more chronic conditions for participants without multimorbidity or the new report of 1 or more conditions for those with multimorbidity. Cox regression models were performed to calculate the hazard ratios and 95% confidence intervals (CIs) of the associations between sleep behaviors and the progression of multimorbidity. RESULTS: Short sleep duration and poor sleep quality were associated with the progression of multimorbidity independently and jointly, especially in those less than 65 years and females. The U-shaped dose-response relationships were observed between nighttime and total sleep duration and the progression of multimorbidity. Persistent short and unsteadily changed sleep behaviors increased the risk of multimorbidity progression. Individuals sleeping ≤5 h/night with 5-7 restless days/week had 1.53 times higher risk of multimorbidity progression (95% CI: 1.37-1.71), compared to those sleeping 7-8 h/night with <1 restless day/week. CONCLUSIONS: Short sleep duration and poor sleep quality were independently and jointly associated with a higher risk of multimorbidity progression in a mid-to-older population. Optimal sleep duration and sleep quality should be emphasized in multimorbidity prevention and control.
引用
- Zhou Y, Ni Y, Jones M, et al. Sleep Behaviors and Progression of Multimorbidity in Middle-Aged and Older Adults: A Prospective Cohort Study From China. J Gerontol A Biol Sci Med Sci. 2023. PMID: 36943283. doi:10.1093/gerona/glad087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。